Goodwin Guides Avalo Therapeutics on Pricing of $430 Million Public Offering
May 08, 2026
May 08, 2026
BOSTON, Massachusetts, May 8 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:
* * *
Goodwin Guides Avalo Therapeutics on Pricing of $430 Million Public Offering
The Life Sciences team advised Avalo Therapeutics, Inc. ("Avalo") on the pricing of its underwritten public offering of 22,899,500 shares of common stock, inclusive of the underwriters' option, and, in lieu of common stock to certain investors, pre-f . . .
* * *
Goodwin Guides Avalo Therapeutics on Pricing of $430 Million Public Offering
The Life Sciences team advised Avalo Therapeutics, Inc. ("Avalo") on the pricing of its underwritten public offering of 22,899,500 shares of common stock, inclusive of the underwriters' option, and, in lieu of common stock to certain investors, pre-f . . .